ABHD1 Gene Lung Alpha-Beta Hydrolase Deficiency Type 1 NGS Genetic DNA Test
Introduction to the ABHD1 Gene Test
The ABHD1 Gene Lung Alpha-Beta Hydrolase Deficiency Type 1 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify mutations in the ABHD1 gene, which can lead to metabolic disorders. Understanding these genetic variations is crucial for early diagnosis, treatment planning, and family counseling.
What the Test Measures
This test detects specific genetic mutations associated with lung alpha-beta hydrolase deficiency. By analyzing the ABHD1 gene through Next-Generation Sequencing (NGS) technology, healthcare providers can gain insights into an individual’s genetic predisposition to certain metabolic disorders.
Who Should Consider This Test?
Individuals who may benefit from this test include:
- Those with a family history of lung alpha-beta hydrolase deficiency.
- Patients exhibiting symptoms related to metabolic disorders.
- Individuals seeking genetic counseling for family planning.
Benefits of Taking the Test
Taking the ABHD1 Gene test offers several advantages:
- Early detection of potential metabolic disorders.
- Informed decision-making regarding treatment options.
- Family planning and risk assessment for future generations.
Understanding Your Results
Results from this test are typically available within 3 to 4 weeks. A healthcare provider will help interpret the findings, providing guidance on the implications of any detected mutations and discussing potential next steps in management or treatment.
Test Pricing
| Price Type | Amount (KSh) |
|---|---|
| Discount Price | 40,000 |
| Regular Price | 56,000 |
Book Your Test Today
We have branches across Kenya, making it convenient for you to access our services. To book the ABHD1 Gene Lung Alpha-Beta Hydrolase Deficiency Type 1 NGS Genetic DNA Test, please call or WhatsApp us at +254711564616. Take the first step towards better health today!
